Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2008 Jun 06;28323:15921-31. doi: 10.1074/jbc.M710302200.
Show Gene links
Show Anatomy links
Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus.
Ma C
,
Soto CS
,
Ohigashi Y
,
Taylor A
,
Bournas V
,
Glawe B
,
Udo MK
,
Degrado WF
,
Lamb RA
,
Pinto LH
.
???displayArticle.abstract???
The influenza B virus BM2 proton-selective ion channel is essential for virus uncoating, a process that occurs in the acidic environment of the endosome. The BM2 channel causes acidification of the interior of the virus particle, which results in dissociation of the viral membrane protein from the ribonucleo-protein core. The BM2 protein is similar to the A/M2 protein ion channel of influenza A virus (A/M2) in that it contains an HXXXW motif. Unlike the A/M2 protein, the BM2 protein is not inhibited by the antiviral drug amantadine. We used mutagenesis to ascertain the pore-lining residues of the BM2 ion channel. The specific activity (relative to wild type), reversal voltage, and susceptibility to modification by (2-aminoethyl)-methane thiosulfonate and N-ethylmaleimide of cysteine mutant proteins were measured in oocytes. It was found that mutation of transmembrane domain residues Ser(9), Ser(12), Phe(13), Ser(16), His(19), and Trp(23) to cysteine were most disruptive for ion channel function. These cysteine mutants were also most susceptible to (2-aminoethyl)-methane thiosulfonate and N-ethylmaleimide modification. Furthermore, considerable amounts of dimer were formed in the absence of oxidative reagents when cysteine was introduced at positions Ser(9), Ser(12), Ser(16), or Trp(23). Based on these experimental data, a BM2 transmembrane domain model is proposed. The presence of polar residues in the pore is a probable explanation for the amantadine insensitivity of the BM2 protein and suggests that related but more polar compounds might serve as useful inhibitors of the protein.
Balannik,
The oligomeric state of the active BM2 ion channel protein of influenza B virus.
2008, Pubmed
Balannik,
The oligomeric state of the active BM2 ion channel protein of influenza B virus.
2008,
Pubmed
Bauer,
The influenza virus M2 ion channel protein: probing the structure of the transmembrane domain in intact cells by using engineered disulfide cross-linking.
1999,
Pubmed
Beumer,
Whole-mount immunohistochemistry on Xenopus embryos using far-red fluorescent dyes.
1995,
Pubmed
,
Xenbase
Castrucci,
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein.
1995,
Pubmed
Chizhmakov,
Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells.
1996,
Pubmed
DAVIES,
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).
1964,
Pubmed
DeGrado,
Protein design, a minimalist approach.
1989,
Pubmed
Gandhi,
Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein.
1999,
Pubmed
,
Xenbase
Hatta,
Influenza B virus requires BM2 protein for replication.
2004,
Pubmed
Holmgren,
On the use of thiol-modifying agents to determine channel topology.
1996,
Pubmed
,
Xenbase
Kaplan,
The yeast mitochondrial citrate transport protein. Probing the secondary structure of transmembrane domain iv and identification of residues that likely comprise a portion of the citrate translocation pathway.
2000,
Pubmed
Kovacs,
Helix tilt of the M2 transmembrane peptide from influenza A virus: an intrinsic property.
2000,
Pubmed
Lear,
Synthetic amphiphilic peptide models for protein ion channels.
1988,
Pubmed
Lin,
Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus.
2001,
Pubmed
Ma,
The mitochondrial citrate transport protein: probing the secondary structure of transmembrane domain III, identification of residues that likely comprise a portion of the citrate transport pathway, and development of a model for the putative TMDIII-TMDIII' interface.
2004,
Pubmed
Martin,
Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.
1991,
Pubmed
Mould,
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes.
2003,
Pubmed
,
Xenbase
Mould,
Permeation and activation of the M2 ion channel of influenza A virus.
2000,
Pubmed
,
Xenbase
Nishimura,
The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR.
2002,
Pubmed
North,
D(n)-symmetrical tertiary templates for the design of tubular proteins.
2001,
Pubmed
Paterson,
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface.
2003,
Pubmed
Pinto,
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity.
1997,
Pubmed
,
Xenbase
Pinto,
Influenza virus M2 protein has ion channel activity.
1992,
Pubmed
,
Xenbase
Pinto,
The M2 proton channels of influenza A and B viruses.
2006,
Pubmed
Sakaguchi,
The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer.
1997,
Pubmed
Schnell,
Structure and mechanism of the M2 proton channel of influenza A virus.
2008,
Pubmed
Schwieters,
The Xplor-NIH NMR molecular structure determination package.
2003,
Pubmed
Shimbo,
Ion selectivity and activation of the M2 ion channel of influenza virus.
1996,
Pubmed
,
Xenbase
Shuck,
Analysis of the pore structure of the influenza A virus M(2) ion channel by the substituted-cysteine accessibility method.
2000,
Pubmed
,
Xenbase
Song,
Transmembrane domain of M2 protein from influenza A virus studied by solid-state (15)N polarization inversion spin exchange at magic angle NMR.
2000,
Pubmed
Stouffer,
Structural basis for the function and inhibition of an influenza virus proton channel.
2008,
Pubmed
Takeda,
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
2002,
Pubmed
Tian,
Expression and initial structural insights from solid-state NMR of the M2 proton channel from influenza A virus.
2002,
Pubmed
Tian,
Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers.
2003,
Pubmed
Venkataraman,
Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of influenza A virus.
2005,
Pubmed
,
Xenbase
Wang,
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
1993,
Pubmed
,
Xenbase
Wang,
Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells.
1994,
Pubmed
Wang,
Structure of the transmembrane region of the M2 protein H(+) channel.
2001,
Pubmed
Xiang,
Extending the accuracy limits of prediction for side-chain conformations.
2001,
Pubmed
